Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Acting Chief Financial Officer

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on proprietary Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients suffering from cancer. Its lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. The company is also developing a TRACIr costimulatory bispecific product candidate against programmed death-ligand 1 and Cluster of Differentiation 28 designed to improve the anti-tumor activity of T cells. In addition, its PSMA-TRACTr is designed to target PSMA, a protein expressed in prostate cancer tumors and the vasculature of other tumors; EGFR-TRACTr is designed to target EGFR in various cancer types with multiple approved monoclonal antibodies; and TROP2-TRACTr is designed to target TROP2, a clinically validated anti-tumor target for which there is an approved anti-TROP2 antibody-drug conjugate. The company was incorporated in 2017 and is headquartered in San Diego, California.

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on proprietary Tumor Activated T Cell...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-29	Premium	sold	Premium	Premium	Premium	-
2024-02-29	Premium	acquired	Premium	Premium	Premium	-
2024-02-29	Premium	sold	Premium	Premium	Premium	-
2024-02-29	Premium	acquired	Premium	Premium	Premium	-
2024-02-29	Premium	sold	Premium	Premium	Premium	-
2024-02-29	Premium	sold	Premium	Premium	Premium	-
2024-02-29	Premium	sold	Premium	Premium	Premium	-
2024-02-29	Premium	acquired	Premium	Premium	Premium	-
2024-02-29	Premium	sold	Premium	Premium	Premium	-
2024-02-29	Premium	acquired	Premium	Premium	Premium	-
2024-02-29	Premium	acquired	Premium	Premium	Premium	-
2023-11-13	Premium	bought	Premium	Premium	Premium	-
2023-11-13	Premium	bought	Premium	Premium	Premium	-
2023-11-13	Premium	bought	Premium	Premium	Premium	Acting Chief Financial Officer
2023-07-19	Premium	bought	Premium	Premium	Premium	-
2021-12-29	Premium	sold	Premium	Premium	Premium	-
2021-12-29	Premium	sold	Premium	Premium	Premium	-
2021-12-21	Premium	sold	Premium	Premium	Premium	-
2021-12-21	Premium	sold	Premium	Premium	Premium	-
2021-12-16	Premium	sold	Premium	Premium	Premium	-
2021-12-16	Premium	sold	Premium	Premium	Premium	-
2021-06-15	Premium	bought	Premium	Premium	Premium	-
2021-06-15	Premium	bought	Premium	Premium	Premium	Acting Chief Financial Officer
2021-06-15	Premium	acquired	Premium	Premium	Premium	-
2021-06-15	Premium	bought	Premium	Premium	Premium	-

JANX - Janux Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for JANX